Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

from Latest Science News -- ScienceDaily https://ift.tt/3hpjKKi

SUBSCRIBE TO OUR NEWSLETTER

Related Posts :

“Work hard in silence, let your success be your noise"

0 Response to "Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial"

Post a Comment

ad

Search Your Job